Aaron Goodman: An informative paper about CD19 CART timing of complications

Aaron Goodman shared on X about a recent paper by Nausheen Ahmed et al. titled “Optimizing the Post-CAR T Monitoring Period for Axicabtagene Ciloleucel, Tisagenlecleucel, and Lisocabtagene Maraleucel” published in ASH Publications.

Authors: Nausheen Ahmed, William Wesson, Forat Lutfi, David Porter, Veronika Bachanova, Loretta Nastoupil, Miguel-Angel Perales, Richard Maziarz, Jamie Brower, Gunjan Shah, Andy Chen, Olalekan Oluwole, Stephen Schuster, Michael Bishop, Joseph McGuirk, Peter Riedell

“An informative paper CD19 CART timing of complications. Nearly all CRS/ICANS events occur during first 14 days which inform intensity/timing of monitoring period. Late non relapse death driven by infection. This figure is good for presentations!”

Source: Aaron Goodman/X

Aaron Goodman is a Hematologist/ Oncologist and an Associate Professor of Medicine at the University of California, San Diego.

He is a member of the National Comprehensive Cancer Network (NCCN) guideline committee for both cutaneous NHLs and T-cell NHLs. Dr. Goodman is a well-known physician-scientist, educator, advocate, and social media influencer.